Circulating sLR11 levels predict severity of pulmonary hypertension due to left heart disease.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 24 08 2021
accepted: 07 12 2021
entrez: 29 12 2021
pubmed: 30 12 2021
medline: 18 1 2022
Statut: epublish

Résumé

Heart failure is a severe condition often involving pulmonary hypertension (PH). Soluble low-density lipoprotein receptor with 11 ligand-binding repeats (sLR11) has been associated with pulmonary artery hypertension. We examined whether sLR11 correlates with PH in left heart disease and can be used as a predictive marker. We retrospectively analyzed patients with severe mitral regurgitation who underwent right heart catheterization before surgery for valve replacement or valvuloplasty from November 2005 to October 2012 at Juntendo University. We measured sLR11 levels before right heart catheterization and analyzed correlations with pulmonary hemodynamics. We compared prognoses between a group with normal sLR11 (≤9.4 ng/ml) and a group with high sLR11 (>9.4 ng/ml). Follow-up was continued for 5 years, with end points of hospitalization due to HF and death due to cardiovascular disease. Among 34 patients who met the inclusion criteria, sLR11 correlated with mean pulmonary artery pressure (r = 0.54, p<0.001), transpulmonary pressure gradient (r = 0.42, p = 0.012), pulmonary vascular resistance (r = 0.36, p<0.05), and log brain natriuretic peptide (BNP). However, logBNP did not correlate with pulmonary vascular resistance (p = 0.6). Levels of sLR11 were significantly higher in the 10 patients with PH (14.4±4.3 ng/ml) than in patients without PH (9.9±3.9 ng/ml; p = 0.002). At 5 years, the event rate was higher in the high-sLR11 group than in the normal-sLR11 group. The high-sLR11 group showed 5 hospitalizations due to HF (25.0%) and 2 deaths (10.0%), whereas the normal-sLR11 group showed no hospitalizations or deaths. Analyses using receiver operating characteristic curves showed a higher area under the concentration-time curve (AUC) for sLR11 level (AUC = 0.85; 95% confidence interval (CI) = 0.72-0.98) than for BNP (AUC = 0.80, 95%CI = 0.62-0.99) in the diagnosis of PH in left heart disease. Concentration of sLR11 is associated with severity of PH and offers a strong predictor of severe mitral regurgitation in patients after surgery.

Sections du résumé

BACKGROUND
Heart failure is a severe condition often involving pulmonary hypertension (PH). Soluble low-density lipoprotein receptor with 11 ligand-binding repeats (sLR11) has been associated with pulmonary artery hypertension. We examined whether sLR11 correlates with PH in left heart disease and can be used as a predictive marker.
METHOD
We retrospectively analyzed patients with severe mitral regurgitation who underwent right heart catheterization before surgery for valve replacement or valvuloplasty from November 2005 to October 2012 at Juntendo University. We measured sLR11 levels before right heart catheterization and analyzed correlations with pulmonary hemodynamics. We compared prognoses between a group with normal sLR11 (≤9.4 ng/ml) and a group with high sLR11 (>9.4 ng/ml). Follow-up was continued for 5 years, with end points of hospitalization due to HF and death due to cardiovascular disease.
RESULTS
Among 34 patients who met the inclusion criteria, sLR11 correlated with mean pulmonary artery pressure (r = 0.54, p<0.001), transpulmonary pressure gradient (r = 0.42, p = 0.012), pulmonary vascular resistance (r = 0.36, p<0.05), and log brain natriuretic peptide (BNP). However, logBNP did not correlate with pulmonary vascular resistance (p = 0.6). Levels of sLR11 were significantly higher in the 10 patients with PH (14.4±4.3 ng/ml) than in patients without PH (9.9±3.9 ng/ml; p = 0.002). At 5 years, the event rate was higher in the high-sLR11 group than in the normal-sLR11 group. The high-sLR11 group showed 5 hospitalizations due to HF (25.0%) and 2 deaths (10.0%), whereas the normal-sLR11 group showed no hospitalizations or deaths. Analyses using receiver operating characteristic curves showed a higher area under the concentration-time curve (AUC) for sLR11 level (AUC = 0.85; 95% confidence interval (CI) = 0.72-0.98) than for BNP (AUC = 0.80, 95%CI = 0.62-0.99) in the diagnosis of PH in left heart disease.
CONCLUSIONS
Concentration of sLR11 is associated with severity of PH and offers a strong predictor of severe mitral regurgitation in patients after surgery.

Identifiants

pubmed: 34965280
doi: 10.1371/journal.pone.0261753
pii: PONE-D-21-24785
pmc: PMC8716052
doi:

Substances chimiques

Biomarkers 0
LDL-Receptor Related Proteins 0
Membrane Transport Proteins 0
SORL1 protein, human 0

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0261753

Déclaration de conflit d'intérêts

Hiroyuki Ebinuma is a paid employee of Tsukuba Research Institute, Sekisui Medical Co. Ltd. There are no patents, products in development or marketed products associated with this research to declare. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Références

Lab Invest. 1988 Feb;58(2):184-95
pubmed: 3123799
Circulation. 2013 Oct 15;128(16):1810-52
pubmed: 23741057
Circulation. 2002 Apr 16;105(15):1830-6
pubmed: 11956127
Curr Cardiol Rep. 2019 Nov 25;21(12):151
pubmed: 31768665
Intern Emerg Med. 2019 Mar;14(2):239-247
pubmed: 30276661
Atherosclerosis. 2014 Nov;237(1):374-8
pubmed: 25443876
Eur Heart J Cardiovasc Imaging. 2015 Mar;16(3):233-70
pubmed: 25712077
J Am Coll Cardiol. 2004 Mar 3;43(5):764-70
pubmed: 14998614
Turk Kardiyol Dern Ars. 2014 Oct;42 Suppl 1:55-66
pubmed: 25697034
Circulation. 2017 Jun 20;135(25):e1159-e1195
pubmed: 28298458
Eur J Cardiovasc Nurs. 2008 Dec;7(4):257-8
pubmed: 19013409
Arterioscler Thromb Vasc Biol. 2016 Sep;36(9):1972-9
pubmed: 27493099
J Clin Invest. 2008 Aug;118(8):2733-46
pubmed: 18618022
Nat Commun. 2015 Nov 20;6:8951
pubmed: 26584636
Am J Cardiol. 2001 Oct 1;88(7):823-4
pubmed: 11589862
Eur Heart J. 2016 Dec 14;37(47):3515-3522
pubmed: 27354049
Eur Heart J. 2016 Jan 1;37(1):67-119
pubmed: 26320113
J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D100-8
pubmed: 24355634
Kardiol Pol. 2015;73(12):1127-206
pubmed: 26727670
Eur J Heart Fail. 2016 Aug;18(8):891-975
pubmed: 27207191
J Am Soc Echocardiogr. 2010 Jul;23(7):685-713; quiz 786-8
pubmed: 20620859
Chest. 2013 Mar;143(3):758-766
pubmed: 23580984
Eur J Heart Fail. 2007 May;9(5):518-24
pubmed: 17064961
Medicine (Baltimore). 2020 Apr;99(16):e19089
pubmed: 32311918
J Heart Lung Transplant. 2014 Mar;33(3):289-97
pubmed: 24462554
J Heart Lung Transplant. 2012 Sep;31(9):913-33
pubmed: 22884380
Int Heart J. 2020 May 30;61(3):470-475
pubmed: 32350212
Chest. 2018 Jul;154(1):126-135
pubmed: 29355551
Eur J Heart Fail. 2003 Aug;5(4):481-8
pubmed: 12921809

Auteurs

Yusuke Joki (Y)

Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Bunkyo City, Tokyo, Japan.

Hakuoh Konishi (H)

Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Bunkyo City, Tokyo, Japan.

Hiroyuki Ebinuma (H)

Tsukuba Research Institute, Sekisui Medical Co Ltd, Ryugasaki, Japan.

Kiyoshi Takasu (K)

Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Bunkyo City, Tokyo, Japan.

Tohru Minamino (T)

Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Bunkyo City, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH